ATE415623T1 - Verfahren und vorrichtung zur messung der aktivierung von neutrophilen zellen - Google Patents

Verfahren und vorrichtung zur messung der aktivierung von neutrophilen zellen

Info

Publication number
ATE415623T1
ATE415623T1 AT05714373T AT05714373T ATE415623T1 AT E415623 T1 ATE415623 T1 AT E415623T1 AT 05714373 T AT05714373 T AT 05714373T AT 05714373 T AT05714373 T AT 05714373T AT E415623 T1 ATE415623 T1 AT E415623T1
Authority
AT
Austria
Prior art keywords
mpo
cells
sample
levels
active
Prior art date
Application number
AT05714373T
Other languages
English (en)
Inventor
Didier Serteyn
Ginette Dupont
Thierry Franck
Stephane Kohnen
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Application granted granted Critical
Publication of ATE415623T1 publication Critical patent/ATE415623T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05714373T 2004-02-06 2005-02-07 Verfahren und vorrichtung zur messung der aktivierung von neutrophilen zellen ATE415623T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04447027 2004-02-06

Publications (1)

Publication Number Publication Date
ATE415623T1 true ATE415623T1 (de) 2008-12-15

Family

ID=34833847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05714373T ATE415623T1 (de) 2004-02-06 2005-02-07 Verfahren und vorrichtung zur messung der aktivierung von neutrophilen zellen

Country Status (8)

Country Link
US (1) US8399208B2 (de)
EP (1) EP1711817B1 (de)
AT (1) ATE415623T1 (de)
CA (1) CA2554899C (de)
DE (2) DE602005011250D1 (de)
ES (1) ES2318459T3 (de)
NZ (1) NZ548816A (de)
WO (1) WO2005075986A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008144850A1 (en) * 2007-05-30 2008-12-04 Advanced Diagnostic Systems Ltd Assay for determining risk of development of allergic disorders
ES2355299T3 (es) * 2007-07-20 2011-03-24 Université De Liége Método combinado para la medición secuencial de (1) la fracción enzimáticamente activa y (2) la cantidad total de una enzima.
US20090053747A1 (en) * 2007-08-21 2009-02-26 Mattingly Phillip G Measurement of Haloperoxidase Activity With Chemiluminescent Detection
US20090162876A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Myeloperoxidase assays
US20120315650A1 (en) * 2011-05-19 2012-12-13 Baxter International, Inc. Detection of circulating adamts13-antibody complexes
CN102680676B (zh) * 2011-07-29 2015-06-10 南京诺尔曼生物技术有限公司 髓过氧化物酶(myeloperoxidase MPO)测定试剂盒(胶乳增强免疫比浊法)
CA2878094A1 (en) * 2012-06-27 2014-01-03 Siscapa Assay Technologies, Inc. Multipurpose mass spectrometric assay panels for peptides
CN103604476B (zh) * 2013-11-11 2016-02-10 鲁东大学 一种测量水气耦合滴灌水气出流量的系统与方法
CN103727992B (zh) * 2013-11-11 2016-02-10 鲁东大学 一种测量氧灌水气出流均匀度的系统与方法
CN104730019B (zh) * 2015-04-08 2017-04-19 安徽中烟工业有限责任公司 一种体外评价卷烟及烟草安全性的方法
CN106908601B (zh) * 2017-03-06 2019-02-12 海格德生物科技（深圳）有限公司 人髓过氧化物酶活性及总量检测试剂盒及检测方法和制备方法
CN108445215A (zh) * 2018-02-01 2018-08-24 浙江艾明德生物科技有限公司 一种定量检测髓过氧化物酶的试剂盒及制备方法
EP3904876A1 (de) * 2020-04-28 2021-11-03 Universitat Politècnica De Catalunya Faltbare fluidische vorrichtung und verfahren zur biomarkendetektion in körperflüssigkeiten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460961A (en) * 1988-06-14 1995-10-24 La Region Wallonne Human myeloperoxidase and its therapeutic application
JP2614155B2 (ja) * 1991-06-18 1997-05-28 株式会社三和化学研究所 ヒト顆粒球エラスターゼの免疫学的測定方法
US5552292A (en) * 1993-01-18 1996-09-03 Ikagaku Co., Ltd. Method of screening for colorectal cancer
US5698518A (en) * 1994-03-30 1997-12-16 Oklahoma Medical Research Foundation Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
GB9811414D0 (en) 1998-05-28 1998-07-22 Imp College Innovations Ltd Method of measuring enzyme activity
BE1013881A6 (fr) * 2000-12-21 2002-11-05 Univ Bruxelles Fractions de ldl oxydees, procede d'obtention et utilisation a but diagnostique ou therapeutique.
GB0318110D0 (en) * 2003-08-01 2003-09-03 Isaeo Ltd Methods and kits for detecting an enzyme capable of modifying a nucleic acid
ES2355299T3 (es) * 2007-07-20 2011-03-24 Université De Liége Método combinado para la medición secuencial de (1) la fracción enzimáticamente activa y (2) la cantidad total de una enzima.

Also Published As

Publication number Publication date
CA2554899A1 (en) 2005-08-18
EP1711817A2 (de) 2006-10-18
NZ548816A (en) 2009-12-24
WO2005075986A2 (en) 2005-08-18
US20080233600A1 (en) 2008-09-25
WO2005075986A3 (en) 2006-01-26
DE202005020939U1 (de) 2007-03-08
DE602005011250D1 (de) 2009-01-08
ES2318459T3 (es) 2009-05-01
US8399208B2 (en) 2013-03-19
EP1711817B1 (de) 2008-11-26
CA2554899C (en) 2013-01-29

Similar Documents

Publication Publication Date Title
ATE415623T1 (de) Verfahren und vorrichtung zur messung der aktivierung von neutrophilen zellen
Rehfeld et al. Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples
Kawamura et al. Development of homogeneous luminescence assays for histone demethylase catalysis and binding
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
Yang et al. Development of novel portable and reusable fiber optical chemiluminescent biosensor and its application for sensitive detection of microcystin-LR
CA2623653A1 (en) Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis
McNamee et al. Development of a planar waveguide microarray for the monitoring and early detection of five harmful algal toxins in water and cultures
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
ATE386936T1 (de) Selbst-kalibrierendes system für magnetisches bindungs-verfahren
JP2010029187A (ja) 生体サンプル中の希有な事象の分析のための高感度マルチパラメータ法
BR112012023984A2 (pt) compensação residual para um biossensor
DE602005009819D1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
CN201707336U (zh) 快速定量检测心肌肌钙蛋白i的试条装置
DK1982182T3 (da) Hidtil ukendt tør-stick-indretningskonstruktion og fremgangsmåde til bestemmelse af en analyt i en prøve under anvendelse af denne tør-stick-indretning
DE60030291D1 (de) Fluoreszenzintenstitätsmethode zur bestimmung der bindung zwischen proteinen oder peptiden
JP6893639B2 (ja) がんの判定方法、がんの判定のための装置及びコンピュータプログラム
CN1924581A (zh) 前列腺特异性抗原化学发光定量检测试剂盒
EP2167676B1 (de) Kit zur sequentiellen Messung (1.) der enzymatisch aktiven Fraktion und (2.) der Gesamtmenge eines Enzyms
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
Mello Potential contribution of ELISA and LFI assays to assessment of the oxidative stress condition based on 8-oxodG biomarker
WO2010128193A1 (es) Método para el diagnóstico, pronóstico y/o tratamiento del lupus eritematoso sistémico
Oikonomidis et al. Serial measurement of cardiac troponin I in hospitalised dogs with canine parvoviral enteritis: Association with outcome and canine pancreas-specific lipase concentration
EP2089546A4 (de) Diagnoseverfahren für osteoarthritis
KR900014887A (ko) 완전 세포에 적용할 수 있는 효소 분석 키트 및 방법
US11982675B2 (en) Method of assessing ABC transporter activity using fluorescent dye accumulation assay

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties